Rarity PBC Raises $4.6 Million Seed Financing to Advance Gene Therapy for ADA-SCID
LOS ANGELES–(BUSINESS WIRE)–Rarity PBC, a Public Benefit Corporation dedicated to expanding the availability of transformative gene therapies for rare diseases, today announced the closing of a $4.6 million seed financing led by biotech investor Steve…